vfend

Generic: voriconazole

Labeler: roerig
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name vfend
Generic Name voriconazole
Labeler roerig
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

voriconazole 10 mg/mL

Manufacturer
Roerig

Identifiers & Regulatory

Product NDC 0049-3190
Product ID 0049-3190_3dbb97e5-3516-4549-b9f3-e256e9cd0511
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021267
Marketing Start 2002-05-24
Marketing End 2027-11-30

Pharmacologic Class

Established (EPC)
azole antifungal [epc]
Mechanism of Action
cytochrome p450 3a4 inhibitors [moa] cytochrome p450 2c19 inhibitors [moa] cytochrome p450 2c9 inhibitors [moa]
Chemical Structure
azoles [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00493190
Hyphenated Format 0049-3190

Supplemental Identifiers

RxCUI
351209 352220
UNII
JFU09I87TR
NUI
N0000175487 M0002083 N0000182141 N0000182140 N0000185504

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vfend (source: ndc)
Generic Name voriconazole (source: ndc)
Application Number NDA021267 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (0049-3190-01) / 20 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (1)

Ingredients (1)

voriconazole (10 mg/mL)

Linked Drug Pages (2)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "3dbb97e5-3516-4549-b9f3-e256e9cd0511", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "unii": ["JFU09I87TR"], "rxcui": ["351209", "352220"], "spl_set_id": ["dac26bcd-7a59-401f-9f66-a0649767cece"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Roerig"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (0049-3190-01)  / 20 mL in 1 VIAL, SINGLE-USE", "package_ndc": "0049-3190-01", "marketing_end_date": "20271130", "marketing_start_date": "20020524"}], "brand_name": "VFEND", "product_id": "0049-3190_3dbb97e5-3516-4549-b9f3-e256e9cd0511", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "0049-3190", "generic_name": "Voriconazole", "labeler_name": "Roerig", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VFEND", "active_ingredients": [{"name": "VORICONAZOLE", "strength": "10 mg/mL"}], "application_number": "NDA021267", "marketing_category": "NDA", "marketing_end_date": "20271130", "marketing_start_date": "20020524"}